ArticleTheory in biosciences = Theorie in den Biowissenschaften2025
A novel passivity-based design for Lipschitz nonlinear systems with application to hepatitis B disease.
Article in Theory in biosciences = Theorie in den Biowissenschaften, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In this paper, an innovative passive formulation has been developed for a wide range of nonlinear systems. During this formulation, a stable and passive state-observer is provided which leads to have a passive closed-loop system. Some remarkable definitions and charts are presented for time-invariant and time-varying Lipschitz systems in four different control scenarios. From a different perspective, a novel interconnection has been established which links the passivity of subsystems with passivity/stability of the closed-loop system. All definitions have been arranged according to the systematic approach named "virtually Euler-Lagrange" form of passivation. Since some design conditions will be released due to using the mentioned method and definitions, the process of analysis and design will be simplified. The proposed passivity-based controller has been applied to treat hepatitis B virus infection disease in several scenarios. All the proposed definitions have been validated by the simulation results.
Indexed as
Identifiers
40958015What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.